Developer docs
API playgroundTry for free, no card

Search company profiles

SATB2 Gene Foundation

Full company profile

uuid0059khg

Namestring
SATB2 Gene Foundation
Legal namestring
SATB2 Gene Foundation, Inc.
Websiteurl
satb2gene.org
Company typeenum
Private
Founded yearint
2012
Descriptiontext

The SATB2 Gene Foundation, Inc. is a 501(c)(3) nonprofit patient advocacy organization established to support families affected by SATB2-associated syndrome (SAS), a rare neurodevelopmental disorder caused by variants in the SATB2 gene on chromosome 2q33.1. Headquartered in Lilburn, Georgia, the foundation operates with a small staff (2 employees) supported by an 11-member volunteer Board of Directors and a 6-member Medical and Scientific Advisory Board. Its mission is delivered through three coordinated program areas: family support (regional support network, Facebook community, virtual meetups, biennial conferences, iPad/AAC communication grants); research infrastructure (a SAS Clinical Registry at Arkansas Children's Hospital with over 200 enrolled families, and an iPSC biobank of 8 patient and control cell lines distributed to academic researchers via Material Transfer Agreement); and education (multilingual information sheets in 17 languages plus symptom-specific clinical guides).

The foundation generates revenue from tax-deductible individual donations, research grants, merchandise sales, and conference sponsorships ranging from $250 (Friend) to $10,000 (Platinum). It maintains an international network of seven national partner organizations across Australia/New Zealand, Europe, France, Italy, Netherlands/Belgium, Spain, and the UK, and is a member of Global Genes, NORD, and COMBINEDBrain. From 2019 to 2025 it distributed over $150,000 in research grants to investigators studying SATB2 function and therapeutic interventions. In June 2025 the foundation hired its first Executive Director, Susan Comparato, marking the transition to professional management while Founder/President Allison Kaczenski continues in a leadership role. The organization does not generate commercial revenue from its patient-facing services, which are provided free of charge.

Short descriptiontext

The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families affected by SATB2-associated syndrome through peer-led family support networks, clinical and iPSC biobank research infrastructure, multilingual educational resources, and biennial medical conferences across an international partner network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLilburn, United States
HQ citystring
Lilburn
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
rare disease advocacy, patient support services, family support network, genetic disorder research, medical information resources
Industry3 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAG
Disability Services & Independent Living Support
SECONDARYBPAGAEAC
Family & Parenting Support Services
Business & Public Services/Nonprofit, NGO & Social Services/Social Services & Community Support (Food, Housing, Family)
NAICS code3 codes
  • Voluntary Health Organizations813212
  • Individual and Family Services6241
  • Child and Youth Services62411
SIC code2 codes
  • Services-Social Services8300
  • Services-Membership Organizations8600
Product category
Rare Disease Patient Advocacy
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Donations and Charitable Contributions
Typedonations_philanthropy
Description

Tax-deductible donations from individuals, families, and supporters. The foundation is a 501(c)(3) nonprofit organization with EIN 82-3474637. Donations can be made one-time, monthly, quarterly, or annually through the website or PayPal.

satb2gene.org
2Grant Funding
Typegrant_funding
Description

Research grants awarded to academic institutions and researchers studying SATB2-associated syndrome. Also received grants from organizations like Global Genes ($12,500 COVID-19 Continuity of Care grant) and GPD Employee's Foundation for iPad communication grants.

satb2gene.org
3Merchandise Sales
Typemerchandise_sales
Description

Sale of awareness products including apparel (sweatshirts, t-shirts), accessories (hats, ornaments), and yard signs through the organization's shop to raise awareness and funds.

satb2gene.org
4Conference Sponsorships
Typesponsorship
Description

Corporate sponsorships for the biennial SATB2-Associated Syndrome Family & Medical Conference, with sponsorship tiers ranging from $250 (Friend) to $10,000 (Platinum), providing recognition and marketing benefits to sponsors.

satb2gene.org
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families of individuals with SATB2-Associated Syndrome (SAS), also known as Glass Syndrome, a rare neurodevelopmental disorder caused by alterations in the SATB2 gene on chromosome 2q33.1. The Foundation delivers peer-led family support programs, multilingual educational resources, a patient-derived iPSC stem cell biobank for research, a clinical registry, research grant funding, biennial conferences, and awareness merchandise, all provided free of charge to families.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 200 families enrolled in the SAS Clinical Registry to support natural history research
+3 more records
Product overview1 text field

The SATB2 Gene Foundation operates as a non-profit patient advocacy organization offering a coordinated suite of support services, educational resources, and research programs for families affected by SATB2-associated syndrome. The core offerings include the Contact Registry & Resource Portal for family enrollment and resource access, a Family Support Network with regional representatives and Facebook-based peer communities, and grant programs providing iPads with AAC communication apps to qualifying US families. On the research front, the Foundation maintains an iPSC Biobank with patient-derived stem cell lines available to qualified researchers and supports a Clinical Registry at Arkansas Children's Hospital. Educational resources span multilingual information sheets (available in 15+ languages), symptom-specific guides covering communication, bone health, behavior, dental health, and nutrition, plus a library of medical information videos. The Foundation organizes recurring events including biennial Family & Medical Conferences, annual SATB2 Awareness Day (August 22), and Pediatric Multidisciplinary Clinics at Arkansas Children's Hospital. A research grant program funds investigator-initiated studies on SATB2-related topics, while an online shop offers awareness merchandise.

Product and service1 record
1Family Support Network
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1Global Genes Foundation Alliance
Strategic tierCoreTypeStrategic or Co-development Partner
Description

The SATB2 Gene Foundation is a proud member of Global Genes Foundation Alliance, an organization advocating for and partnering with those affected by rare diseases. Global Genes connects, empowers, and inspires the rare disease community with the goal of eliminating daily challenges for 1 in 10 people affected by rare disease globally.

satb2gene.org
2COMBINEDBrain
Strategic tierCoreTypeStrategic or Co-development Partner
Description

COMBINEDBrain (Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders) is a consortium led by patient advocacy foundations working with clinicians, researchers, and pharmaceutical firms to speed the path to clinical treatments for severe rare genetic non-verbal neurodevelopmental disorders by pooling efforts, studies, and data.

satb2gene.org
3National Organization for Rare Disorders (NORD)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

NORD is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. With more than 300 patient organization members, NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.

satb2gene.org
4Rx4Good
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Rx4Good helps deliver on the promise to put patients first by thoughtfully integrating the patient perspective into work, culture, processes, business decisions, and program activities to improve patient outcomes and support business goals.

satb2gene.org
5SATB2 Connect (Australia, New Zealand, Asia Pacific)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International partner for families in Australia, New Zealand, and Asia Pacific region. Led by Dalal D Baumgartner, providing localized support and resources for families in these regions.

satb2gene.org
6SATB2 Europe
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International partner for families in Europe, led by President Erika Stariha. Provides regional support and advocacy for European families affected by SATB2-associated syndrome.

satb2gene.org
7Association Francaise Du SATB2 (France)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

French national partner organization for families in France, led by Camille Gobin. Provides localized French-language support and resources.

satb2gene.org
8SATB2 Italia Associazione Onlus (Italy)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Italian national partner organization led by President Francesco Maule. Provides localized Italian-language support and advocacy for Italian families.

satb2gene.org
9SATB2 Stichting Nederland en Belgie (Netherlands and Belgium)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dutch/Belgian regional partner organization led by Chairperson Ivana Agatonovic. Provides localized Dutch-language support for families in the Benelux region.

satb2gene.org
10Asociación SATB2 España-SAS (Spain)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Spanish national partner organization led by President María Gurrea López. Provides localized Spanish-language support and resources for Spanish families.

satb2gene.org
11SATB2 Gene Trust UK
Strategic tierCoreTypeStrategic or Co-development Partner
Description

UK national partner organization led by Chair Maria Walters. Provides localized UK-based support and advocacy for British families affected by SATB2-associated syndrome.

satb2gene.org
12Arkansas Children's Hospital / University of Kentucky
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Yuri Zarate at Arkansas Children's Hospital leads the SAS Clinical Registry and hosts the only dedicated pediatric multidisciplinary SAS clinic in the United States. Collaboration supports research initiatives and patient care.

satb2gene.org
13Children's Medical Research Institute
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Professor Leszek Lisowski leads a gene therapy proof-of-concept study using donor-funded iPSC lines created through the foundation's community. Project aims to validate AAV-based gene therapy approach for SATB2-Associated Syndrome.

satb2gene.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Phelan-McDermid Syndrome Foundation
TypeDirect peer
Description

Disease-specific patient advocacy foundation supporting families affected by Phelan-McDermid Syndrome, a rare neurodevelopmental disorder. Directly comparable organizational model with family support network, research grant program, clinical registry, and biennial family conferences.

2Angelman Syndrome Foundation
TypeDirect peer
Description

Patient advocacy organization for Angelman Syndrome, a rare neurodevelopmental disorder. Comparable structure with family support, research grants, clinical registry, scientific advisory board, and biennial family/research conferences.

3Rett Syndrome Research Trust
TypeDirect peer
Description

Focused research and advocacy organization for Rett Syndrome. Comparable model combining family support, research grant funding, and active drug development pipeline partnerships.

4Dup15q Alliance
TypeDirect peer
Description

Advocacy foundation for Dup15q syndrome, a rare chromosomal disorder causing neurodevelopmental disabilities. Comparable structure with family support network, clinical registry, research grants, and family conferences.

5CDKL5 Deficiency Disorder Foundation
TypeDirect peer
Description

Patient advocacy foundation for CDKL5 Deficiency Disorder, a rare genetic neurodevelopmental disorder. Comparable structure with family support programs, research grant funding, clinical registry, and multidisciplinary clinic partnerships.

6Pitt Hopkins Research Foundation
TypeDirect peer
Description

Disease-specific foundation for Pitt-Hopkins Syndrome, a rare neurodevelopmental disorder. Comparable structure combining family support, research grants, registry, and active therapeutic development pipeline.

7Smith-Magenis Syndrome Foundation
TypeDirect peer
Description

Patient advocacy foundation for Smith-Magenis Syndrome, a rare genetic neurodevelopmental disorder. Comparable structure with family support network, research grants, biennial conferences, and multidisciplinary clinic partnerships.

8FOXP1 Foundation
TypeDirect peer
Description

Family-led foundation supporting individuals with FOXP1 syndrome, a rare neurodevelopmental disorder. Comparable parent-driven structure with peer support, research funding, and registry development.

9Global Genes
TypeBroad incumbent
Description

Large rare disease advocacy umbrella organization that the SATB2 Gene Foundation is a member of. Provides infrastructure, grants, and cross-disease advocacy resources for disease-specific foundations.

10National Organization for Rare Disorders (NORD)
TypeBroad incumbent
Description

Largest US rare disease patient advocacy organization with 300+ member organizations. SATB2 Gene Foundation is a member. Comparable advocacy mission but operates at scale across all rare diseases rather than focusing on one condition.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles19 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SATB2 Gene Foundation

Rare Disease Patient Advocacysatb2gene.org

The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families affected by SATB2-associated syndrome through peer-led family support networks, clinical and iPSC biobank research infrastructure, multilingual educational resources, and biennial medical conferences across an international partner network.

What SATB2 Gene Foundation does

The SATB2 Gene Foundation, Inc. is a 501(c)(3) nonprofit patient advocacy organization established to support families affected by SATB2-associated syndrome (SAS), a rare neurodevelopmental disorder caused by variants in the SATB2 gene on chromosome 2q33.1. Headquartered in Lilburn, Georgia, the foundation operates with a small staff (2 employees) supported by an 11-member volunteer Board of Directors and a 6-member Medical and Scientific Advisory Board. Its mission is delivered through three coordinated program areas: family support (regional support network, Facebook community, virtual meetups, biennial conferences, iPad/AAC communication grants); research infrastructure (a SAS Clinical Registry at Arkansas Children's Hospital with over 200 enrolled families, and an iPSC biobank of 8 patient and control cell lines distributed to academic researchers via Material Transfer Agreement); and education (multilingual information sheets in 17 languages plus symptom-specific clinical guides).

The foundation generates revenue from tax-deductible individual donations, research grants, merchandise sales, and conference sponsorships ranging from $250 (Friend) to $10,000 (Platinum). It maintains an international network of seven national partner organizations across Australia/New Zealand, Europe, France, Italy, Netherlands/Belgium, Spain, and the UK, and is a member of Global Genes, NORD, and COMBINEDBrain. From 2019 to 2025 it distributed over $150,000 in research grants to investigators studying SATB2 function and therapeutic interventions. In June 2025 the foundation hired its first Executive Director, Susan Comparato, marking the transition to professional management while Founder/President Allison Kaczenski continues in a leadership role. The organization does not generate commercial revenue from its patient-facing services, which are provided free of charge.

SATB2 Gene Foundation firmographics

Firmographics
Name
SATB2 Gene Foundation
Legal name
SATB2 Gene Foundation, Inc.
Website
https://satb2gene.org
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
1–10 employees
Short description
The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families affected by SATB2-associated syndrome through peer-led family support networks, clinical and iPSC biobank research infrastructure, multilingual educational resources, and biennial medical conferences across an international partner network.
Ownership category
akta.pro rank

SATB2 Gene Foundation industry classification

Industry
Product category
Rare Disease Patient Advocacy
NAICS
Voluntary Health Organizations (813212), Individual and Family Services (6241), Child and Youth Services (62411)
SIC
Services-Social Services (8300), Services-Membership Organizations (8600)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYBPAGACAG
Disability Services & Independent Living Support
SECONDARYBPAGAEAC
Family & Parenting Support Services
Business & Public Services/Nonprofit, NGO & Social Services/Social Services & Community Support (Food, Housing, Family)

Keywords

  • Rare disease advocacy
  • Patient support services
  • Family support network
  • Genetic disorder research
  • Medical information resources

Where SATB2 Gene Foundation is headquartered

Location

Headquarters

HQ city
Lilburn
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SATB2 Gene Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Donations and Charitable Contributions: Tax-deductible donations from individuals, families, and supporters. The foundation is a 501(c)(3) nonprofit organization with EIN 82-3474637. Donations can be made one-time, monthly, quarterly, or annually through the website or PayPal.
  2. Grant Funding: Research grants awarded to academic institutions and researchers studying SATB2-associated syndrome. Also received grants from organizations like Global Genes ($12,500 COVID-19 Continuity of Care grant) and GPD Employee's Foundation for iPad communication grants.
  3. Merchandise Sales: Sale of awareness products including apparel (sweatshirts, t-shirts), accessories (hats, ornaments), and yard signs through the organization's shop to raise awareness and funds.
  4. Conference Sponsorships: Corporate sponsorships for the biennial SATB2-Associated Syndrome Family & Medical Conference, with sponsorship tiers ranging from $250 (Friend) to $10,000 (Platinum), providing recognition and marketing benefits to sponsors.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

SATB2 Gene Foundation product offering

Product offering

Core offering

The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families of individuals with SATB2-Associated Syndrome (SAS), also known as Glass Syndrome, a rare neurodevelopmental disorder caused by alterations in the SATB2 gene on chromosome 2q33.1. The Foundation delivers peer-led family support programs, multilingual educational resources, a patient-derived iPSC stem cell biobank for research, a clinical registry, research grant funding, biennial conferences, and awareness merchandise, all provided free of charge to families.

Product overview

The SATB2 Gene Foundation operates as a non-profit patient advocacy organization offering a coordinated suite of support services, educational resources, and research programs for families affected by SATB2-associated syndrome. The core offerings include the Contact Registry & Resource Portal for family enrollment and resource access, a Family Support Network with regional representatives and Facebook-based peer communities, and grant programs providing iPads with AAC communication apps to qualifying US families. On the research front, the Foundation maintains an iPSC Biobank with patient-derived stem cell lines available to qualified researchers and supports a Clinical Registry at Arkansas Children's Hospital. Educational resources span multilingual information sheets (available in 15+ languages), symptom-specific guides covering communication, bone health, behavior, dental health, and nutrition, plus a library of medical information videos. The Foundation organizes recurring events including biennial Family & Medical Conferences, annual SATB2 Awareness Day (August 22), and Pediatric Multidisciplinary Clinics at Arkansas Children's Hospital. A research grant program funds investigator-initiated studies on SATB2-related topics, while an online shop offers awareness merchandise.

Differentiator

Problem solved

Functional benefit

Products and services

  • Family Support Network

Quantifiable outcome

  • Over 200 families enrolled in the SAS Clinical Registry to support natural history research
  • +3 more outcomes

Companies that use SATB2 Gene Foundation

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

SATB2 Gene Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

SATB2 Gene Foundation partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • Global Genes Foundation AlliancecoreStrategic or Co-development PartnerThe SATB2 Gene Foundation is a proud member of Global Genes Foundation Alliance, an organization advocating for and partnering with those affected by rare diseases. Global Genes connects, empowers, and inspires the rare disease community with the goal of eliminating daily challenges for 1 in 10 people affected by rare disease globally.
  • COMBINEDBraincoreStrategic or Co-development PartnerCOMBINEDBrain (Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders) is a consortium led by patient advocacy foundations working with clinicians, researchers, and pharmaceutical firms to speed the path to clinical treatments for severe rare genetic non-verbal neurodevelopmental disorders by pooling efforts, studies, and data.
  • National Organization for Rare Disorders (NORD)coreStrategic or Co-development PartnerNORD is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. With more than 300 patient organization members, NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and patient services.
  • Rx4GoodminorStrategic or Co-development PartnerRx4Good helps deliver on the promise to put patients first by thoughtfully integrating the patient perspective into work, culture, processes, business decisions, and program activities to improve patient outcomes and support business goals.
  • SATB2 Connect (Australia, New Zealand, Asia Pacific)coreStrategic or Co-development PartnerInternational partner for families in Australia, New Zealand, and Asia Pacific region. Led by Dalal D Baumgartner, providing localized support and resources for families in these regions.
  • SATB2 EuropecoreStrategic or Co-development PartnerInternational partner for families in Europe, led by President Erika Stariha. Provides regional support and advocacy for European families affected by SATB2-associated syndrome.
  • Association Francaise Du SATB2 (France)coreStrategic or Co-development PartnerFrench national partner organization for families in France, led by Camille Gobin. Provides localized French-language support and resources.
  • SATB2 Italia Associazione Onlus (Italy)coreStrategic or Co-development PartnerItalian national partner organization led by President Francesco Maule. Provides localized Italian-language support and advocacy for Italian families.
  • SATB2 Stichting Nederland en Belgie (Netherlands and Belgium)coreStrategic or Co-development PartnerDutch/Belgian regional partner organization led by Chairperson Ivana Agatonovic. Provides localized Dutch-language support for families in the Benelux region.
  • Asociación SATB2 España-SAS (Spain)coreStrategic or Co-development PartnerSpanish national partner organization led by President María Gurrea López. Provides localized Spanish-language support and resources for Spanish families.
  • SATB2 Gene Trust UKcoreStrategic or Co-development PartnerUK national partner organization led by Chair Maria Walters. Provides localized UK-based support and advocacy for British families affected by SATB2-associated syndrome.
  • Arkansas Children's Hospital / University of KentuckycoreStrategic or Co-development PartnerDr. Yuri Zarate at Arkansas Children's Hospital leads the SAS Clinical Registry and hosts the only dedicated pediatric multidisciplinary SAS clinic in the United States. Collaboration supports research initiatives and patient care.
  • Children's Medical Research InstitutecoreStrategic or Co-development PartnerProfessor Leszek Lisowski leads a gene therapy proof-of-concept study using donor-funded iPSC lines created through the foundation's community. Project aims to validate AAV-based gene therapy approach for SATB2-Associated Syndrome.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

SATB2 Gene Foundation competitors and assessment

Company assessment

Direct peers

  • Phelan-McDermid Syndrome Foundation: Disease-specific patient advocacy foundation supporting families affected by Phelan-McDermid Syndrome, a rare neurodevelopmental disorder. Directly comparable organizational model with family support network, research grant program, clinical registry, and biennial family conferences.
  • Angelman Syndrome Foundation: Patient advocacy organization for Angelman Syndrome, a rare neurodevelopmental disorder. Comparable structure with family support, research grants, clinical registry, scientific advisory board, and biennial family/research conferences.
  • Rett Syndrome Research Trust: Focused research and advocacy organization for Rett Syndrome. Comparable model combining family support, research grant funding, and active drug development pipeline partnerships.
  • Dup15q Alliance: Advocacy foundation for Dup15q syndrome, a rare chromosomal disorder causing neurodevelopmental disabilities. Comparable structure with family support network, clinical registry, research grants, and family conferences.
  • CDKL5 Deficiency Disorder Foundation: Patient advocacy foundation for CDKL5 Deficiency Disorder, a rare genetic neurodevelopmental disorder. Comparable structure with family support programs, research grant funding, clinical registry, and multidisciplinary clinic partnerships.
  • Pitt Hopkins Research Foundation: Disease-specific foundation for Pitt-Hopkins Syndrome, a rare neurodevelopmental disorder. Comparable structure combining family support, research grants, registry, and active therapeutic development pipeline.
  • Smith-Magenis Syndrome Foundation: Patient advocacy foundation for Smith-Magenis Syndrome, a rare genetic neurodevelopmental disorder. Comparable structure with family support network, research grants, biennial conferences, and multidisciplinary clinic partnerships.
  • FOXP1 Foundation: Family-led foundation supporting individuals with FOXP1 syndrome, a rare neurodevelopmental disorder. Comparable parent-driven structure with peer support, research funding, and registry development.

Broad incumbents

  • Global Genes: Large rare disease advocacy umbrella organization that the SATB2 Gene Foundation is a member of. Provides infrastructure, grants, and cross-disease advocacy resources for disease-specific foundations.
  • National Organization for Rare Disorders (NORD): Largest US rare disease patient advocacy organization with 300+ member organizations. SATB2 Gene Foundation is a member. Comparable advocacy mission but operates at scale across all rare diseases rather than focusing on one condition.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

SATB2 Gene Foundation social profiles

Digital presence

SATB2 Gene Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SATB2 Gene Foundation leadership team

Management profile

Number of profiles

Profiles19 records

SATB2 Gene Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SATB2 Gene Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SATB2 Gene Foundation

What does SATB2 Gene Foundation do?

The SATB2 Gene Foundation is a 501(c)(3) nonprofit patient advocacy organization that supports families of individuals with SATB2-Associated Syndrome (SAS), also known as Glass Syndrome, a rare neurodevelopmental disorder caused by alterations in the SATB2 gene on chromosome 2q33.1. The Foundation delivers peer-led family support programs, multilingual educational resources, a patient-derived iPSC stem cell biobank for research, a clinical registry, research grant funding, biennial conferences, and awareness merchandise, all provided free of charge to families.

Is SATB2 Gene Foundation a public or private company?

SATB2 Gene Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was SATB2 Gene Foundation founded?

SATB2 Gene Foundation was founded in 2012. It employs 1 to 10 people.

Where is SATB2 Gene Foundation based?

SATB2 Gene Foundation is headquartered in Lilburn, United States, in the North America region.

How does SATB2 Gene Foundation make money?

Four revenue lines are on record. Donations and Charitable Contributions are the primary driver. The others are grant Funding, merchandise Sales and conference Sponsorships.

Who are SATB2 Gene Foundation's main competitors?

Direct peers on record are Phelan-McDermid Syndrome Foundation, Angelman Syndrome Foundation, Rett Syndrome Research Trust, Dup15q Alliance, CDKL5 Deficiency Disorder Foundation, Pitt Hopkins Research Foundation, Smith-Magenis Syndrome Foundation and FOXP1 Foundation. Broad incumbents are Global Genes and National Organization for Rare Disorders (NORD).

Does SATB2 Gene Foundation have an API?

No public API is recorded for SATB2 Gene Foundation.

What industry is SATB2 Gene Foundation in?

SATB2 Gene Foundation's product category is Rare Disease Patient Advocacy. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGACAG, Disability Services & Independent Living Support. Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales